(Q38389804)

2 September 2017

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study (English)

1 reference

multicenter clinical trial

2 September 2017

0 references

1 reference

1 reference

deep brain stimulation

1 reference

10

1 reference

2 September 2017

18

Günther Deuschl

0 references

Paul Krack

series ordinal

4

object named as

Paul Krack

1 reference

2 September 2017

1

Witt K

1 reference

2 September 2017

2

Daniels C

1 reference

2 September 2017

3

Reiff J

1 reference

2 September 2017

5

Volkmann J

1 reference

2 September 2017

15

Volker Sturm

1 reference

2 September 2017

6

Markus O Pinsker

1 reference

2 September 2017

7

Martin Krause

1 reference

2 September 2017

8

Volker Tronnier

1 reference

2 September 2017

9

Manja Kloss

1 reference

2 September 2017

11

Lars Wojtecki

1 reference

2 September 2017

12

Kai Bötzel

1 reference

2 September 2017

13

Adrian Danek

1 reference

2 September 2017

14

Rüdiger Hilker

1 reference

2 September 2017

17

Elfriede Karner

1 reference

2 September 2017

Andreas Kupsch

16

1 reference

PubMed ID

18538636

2 September 2017

language of work or name

English

0 references

publication date

4 June 2008

1 reference

2 September 2017

1 reference

2 September 2017

7

1 reference

2 September 2017

7

1 reference

2 September 2017

605-614

1 reference

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

A randomized trial of deep-brain stimulation for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Neuropsychological changes after subthalamic nucleus stimulation: a 12 month follow-up in nine patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Statistical power of studies examining the cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Behavioural disorders, Parkinson's disease and subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Deep brain stimulation: neuropsychological and neuropsychiatric issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Rey Auditory-Verbal Learning Test: structure of a modified German version.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

An inventory for measuring clinical anxiety: psychometric properties

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

[German version of the Snaith-Hamilton-Pleasure Scale (SHAPS-D). Anhedonia in schizophrenic and depressive patients]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

The mania rating scale: scale construction and inter-observer agreement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Untersuchung zur Reliabilität der deutschen Version des PDQ-39: Ein krankheitsspezifischer Fragebogen zur Erfassung der Lebensqualität von Parkinson-Patienten

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

A comparison of methods for measuring cognitive change in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Verbal fluency deficits in Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Postoperative management of subthalamic nucleus stimulation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Is PD-MCI a useful concept?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970114-5

7 January 2021

10.1016/S1474-4422(08)70114-5

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

18538636